Bazedoxifene Acetate,CAS#198481-33-3
Molecular Formula:C32H38N2O5
Purpose:Mainly used to treat osteoporosis in postmenopausal women with increased risk of fractures.
Classification :
PRODUCT DETAILS
Specifications | |
Product Name | 1-((4-(2-(Hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol monoacetate |
CAS No. | 198481-33-3 |
Standard | Enterprise standard |
| |
Items | Standard |
Appearance | Appearance White to off white powder |
Identification
| 1)The retention time of the principal peak is similar to the reference spectrum 2)The infrared absorption spectrum is concordant with the reference spectrum. 3)The UV absorption spectrum is concordant with the reference spectrum. |
Solubility | Amost insoluble in water |
Residue on ignition | ≤0.2% |
Water | ≤1.0% |
Residual solvent | Methanol ≤0 .3% |
Ethanol≤0. 5% | |
Ethyl acetate≤0 . 5 % | |
Toluene≤0 .089% | |
Related Substances | Unidentified single impurity≤0 . 1% |
Total impurities≤0 . 5% | |
Assay(Calculated on anhydrous basis) | 98.0%-102.0% |
Packaging | Inner packaging:two-layer LDPE bags, Outer packaging:cardboard drum, Net weight:25 . 00kg/drum. |
Storage Conditions | Room temperature, seal, dry place |
HOT PRODUCTS
(R)-(+)-3-Chloro-1-Phenyl-1-Propanol,CAS#100306-33-0
2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole,CAS#98809-58-6
(S)-4-(3-chloro-4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-(2-hydroxyMethyl-1-pyrrolidinyl)pyriMidine,CAS#330785-83-6
(S)-4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid,CAS#330785-84-7
Dapoxetine,CAS#119356-77-3
2',4'-Dihydroxyacetophenone,CAS#89-84-9
Bazedoxifene Acetate,CAS#198481-33-3
Vardenafil hydrochloride trihydrate,CAS NO.:330808-88-3
Avanafil, CAS:330784-47-9
Bevenopran,CAS:676500-67-7